The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease

dc.centroFacultad de Medicina
dc.contributor.authorRomero-Fernandez, Wilber
dc.contributor.authorTaura, Jaume J.
dc.contributor.authorCrans, René A. J.
dc.contributor.authorLopez-Cano, Marc
dc.contributor.authorFores-Pons, Ramon
dc.contributor.authorNarváez, Manuel
dc.contributor.authorCarlsson, Jens
dc.contributor.authorCiruela, Francisco
dc.contributor.authorFuxe, Kjell
dc.contributor.authorBorroto-Escuela, Dasiel O.
dc.date.accessioned2026-01-29T11:03:19Z
dc.date.issued2022-07-12
dc.departamentoFisiología Humana, Histología Humana, Anatomía Patológica y Educación Físico Deportiva
dc.description.abstractThe adenosine A2A receptor (A2AR), dopamine D2 receptor (D2R) and metabotropic glutamate receptor type 5 (mGluR5) form A2AR-D2R-mGluR5 heteroreceptor complexes in living cells and in rat striatal neurons. In the current study, we present experimental data supporting the view that the A2AR protomer plays a major role in the inhibitory modulation of the density and the allosteric receptor-receptor interaction within the D2R-mGluR5 heteromeric component of the A2AR-D2R-mGluR5 complex in vitro and in vivo. The A2AR and mGluR5 protomers interact and modulate D2R protomer recognition and signalling upon forming a trimeric complex from these receptors. Expression of A2AR in HEK293T cells co-expressing D2R and mGluR5 resulted in a significant and marked increase in the formation of the D2R-mGluR5 heteromeric component in both bioluminescence resonance energy transfer and proximity ligation assays. A highly significant increase of the the high-affinity component of D2R (D2RKi High) values was found upon cotreatment with the mGluR5 and A2AR agonists in the cells expressing A2AR, D2R and mGluR5 with a significant effect observed also with the mGluR5 agonist alone compared to cells expressing only D2R and mGluR5. In cells co-expressing A2AR, D2R and mGluR5, stimulation of the cells with an mGluR5 agonist like or D2R antagonist fully counteracted the D2R agonist-induced inhibition of the cAMP levels which was not true in cells only expressing mGluR5 and D2R. In agreement, the mGluR5-negative allosteric modulator raseglurant significantly reduced the haloperidol-induced catalepsy in mice, and in A2AR knockout mice, the haloperidol action had almost disappeared, supporting a functional role for mGluR5 and A2AR in enhancing D2R blockade resulting in catalepsy. The results represent a relevant example of integrative activity within higher-order heteroreceptor complexes.
dc.description.sponsorshipKarolinska Institutet (Open access funding)
dc.description.sponsorshipSwedish Research Council (Vetenskapsrådet)
dc.description.sponsorshipParkinsonFonden
dc.description.sponsorshipHjärnfonden
dc.description.sponsorshipKarolinska Institutet Forskningsstiftelser
dc.description.sponsorshipPlan Andaluz de Investigación, Desarrollo e Innovación (PAIDI) – EMERGIA (Junta de Andalucía)
dc.description.sponsorshipOlle Engkvists Stiftelse
dc.description.sponsorshipMCIN/AEI (Ministerio de Ciencia e Innovación / Agencia Estatal de Investigación, España)
dc.description.sponsorshipFEDER (Fondo Europeo de Desarrollo Regional)
dc.description.sponsorshipCERCA Programme (Generalitat de Catalunya) / IDIBELL (institutional support)
dc.identifier.citationRomero-Fernandez, W., Taura, J.J., Crans, R.A.J. et al. The mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease. Mol Neurobiol 59, 5955–5969 (2022). https://doi.org/10.1007/s12035-022-02946-9
dc.identifier.doi10.1007/s12035-022-02946-9
dc.identifier.issn0893-7648
dc.identifier.urihttps://hdl.handle.net/10630/45021
dc.language.isoeng
dc.publisherSpringer
dc.relation.projectIDinfo:eu-repo/grantAgreement/Swedish_Research_Council//2019-01022/SE///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Swedish_Research_Council//62X-00715-50-3/SE///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Swedish_Research_Council//2017-4676/SE///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Hjarnfonden//F02018-0286/SE///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Hjarnfonden//F02019-0296/SE///
dc.relation.projectIDinfo:eu-repo/grantAgreement/PAIDI/EMERGIA/2020-39318/ES///
dc.relation.projectIDinfo:eu-repo/grantAgreement/MCIN/AEI/PID2020-118511RB-I00/ES///
dc.relation.projectIDinfo:eu-repo/grantAgreement/Generalitat_de_Catalunya/SGR/2017SGR1604/ES///
dc.rightsAttribution 4.0 Internationalen
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectParkinson, Enfermedad de
dc.subjectDopamina - Receptores
dc.subject.otherHeteroreceptor complexes
dc.subject.otherDopamine D2R receptor
dc.subject.otherAdenosine A2A receptor
dc.subject.otherParkinson’s Disease
dc.subject.otherMetabotropic glutamate receptor subtype 5 (mGluR5)
dc.subject.otherOligomerization
dc.titleThe mGlu5 Receptor Protomer-Mediated Dopamine D2 Receptor Trans-Inhibition Is Dependent on the Adenosine A2A Receptor Protomer: Implications for Parkinson’s Disease
dc.typejournal article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
s12035-022-02946-9.pdf
Size:
1.51 MB
Format:
Adobe Portable Document Format

Collections